Want to see TSE:DMED full AI Analyst Report?
DiagnaMed Holdings Corp. (DMED) Ratios
DiagnaMed Holdings Corp. Ratios
TSE:DMED's free cash flow for Q3 2026 was $-171.99K. For the 2026 fiscal year, TSE:DMED's free cash flow was increased by $0.00 and operating cash flow was $-171.99K. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Sep 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.32 | 0.43 | 1.55 | 4.37 | 15.91 |
| Quick Ratio | 0.32 | 0.43 | 1.55 | 4.37 | 15.91 |
| Cash Ratio | 0.28 | 0.35 | 1.42 | 4.25 | 15.69 |
| Solvency Ratio | -2.11 | 0.37 | -0.23 | -3.06 | -12.97 |
| Operating Cash Flow Ratio | -0.50 | -0.95 | -2.50 | -2.13 | -3.76 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Current Asset Value | $ -450.11K | $ -265.17K | $ 235.89K | $ 1.25M | $ 2.24M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | -0.48 | -0.76 | 2.81 | 1.30 | 1.07 |
| Debt Service Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt to Market Cap | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Debt Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt to EBITDA | 0.13 | 0.32 | 6.07 | 1.39 | 1.21 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Income Per EBT | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 94.19% | 67.59% | 108.49% | 99.65% | 284.80% |
| Return on Assets (ROA) | -648.52% | -248.33% | -192.97% | -70.07% | -81.51% |
| Return on Equity (ROE) | 311.73% | 188.94% | -541.78% | -90.85% | -86.97% |
| Return on Capital Employed (ROCE) | 330.95% | 279.54% | -499.39% | -91.17% | -30.54% |
| Return on Invested Capital (ROIC) | 330.95% | 279.54% | -499.39% | -90.81% | -30.54% |
| Return on Tangible Assets | -648.52% | -248.33% | -192.97% | -70.07% | -81.51% |
| Earnings Yield | -14.31% | -62.58% | -40.86% | -24.75% | -42.59% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.07 | 0.11 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | -545.07 | -499.02 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | -5370.75 | -3416.41 |
| Days of Sales Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | -0.67 | -0.73 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 5370.08 | 3415.68 |
| Operating Cycle | 0.00 | 0.00 | 0.00 | -0.67 | -0.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Free Cash Flow Per Share | -0.00 | -0.01 | -0.01 | -0.01 | -0.01 |
| Dividend Paid and CapEx Coverage Ratio | 0.00 | 0.00 | -266878.50 | 0.00 | 0.00 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | -266878.50 | 0.00 | 0.00 |
| Operating Cash Flow Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow Yield | -3.43% | -55.57% | -34.13% | -17.22% | -12.37% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -7.00 | -1.60 | -2.45 | -4.04 | -2.35 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price-to-Book (P/B) Ratio | -21.78 | -3.02 | 13.26 | 3.67 | 2.04 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -29.17 | -1.80 | -2.93 | -5.81 | -8.09 |
| Price-to-Operating Cash Flow Ratio | -29.17 | -1.80 | -2.93 | -5.81 | -8.09 |
| Price-to-Earnings Growth (PEG) Ratio | -0.05 | 0.03 | -0.26 | 0.10 | 0.00 |
| Enterprise Value Multiple | -6.86 | -1.27 | -25.21 | -2.65 | -1.14 |
| Enterprise Value | 9.62M | 638.38K | 2.52M | 3.00M | 2.22M |
| EV to EBITDA | -6.86 | -1.27 | -25.21 | -2.65 | -1.14 |
| EV to Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EV to Free Cash Flow | -28.62 | -1.44 | -2.36 | -3.81 | -3.92 |
| EV to Operating Cash Flow | -28.62 | -1.44 | -2.36 | -3.81 | -3.92 |
| Tangible Book Value Per Share | -0.00 | -0.00 | 0.00 | 0.02 | 0.03 |
| Shareholders’ Equity Per Share | -0.00 | -0.00 | 0.00 | 0.02 | 0.03 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.02 | -0.01 | -0.02 | -0.01 | -0.03 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 1.00 | 1.00 | 1.00 | 1.00 | 2.85 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.24 | 0.89 | 0.84 | 0.70 | 0.29 |
Currency in CAD
